Home›Stock Screener›Godavari Drugs›Financial Statements

Godavari Drugs Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Godavari Drugs (GODAVARI) reported revenue ₹99 Cr, net profit ₹4 Cr and EPS ₹4.90, with a net profit margin of 3.5% and ROE of 9.3%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Godavari Drugs share price screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 3.51% 2025 data
EBITDA Margin 11.40% 2025 data
Operating Margin 10.00% 2025 data
Return on Assets 2.80% 2025 data
Return on Equity 9.30% 2025 data

Balance Sheet Ratios

Current Ratio 2.93 2025 data
Equity Ratio 30.07% 2025 data
Asset Turnover 0.80 2025 data

GODAVARI Revenue, Net Profit & EBITDA — Year-on-Year Growth

GODAVARI YoY (March 2025 vs Period) — revenue -13.2%, EBITDA -7.7%, expenses -13.7%. Explore GODAVARI intrinsic value to estimate fundamental worth using multiple valuation models.

Revenue Growth
-13.2%
Year-over-Year
EBITDA Growth
-7.7%
Year-over-Year
Expense Growth
-13.7%
Year-over-Year
Assets Growth
+5.9%
Year-over-Year
Equity Growth
+10.3%
Year-over-Year
Operating Cash Flow Growth
-38.9%
Year-over-Year
Investing Cash Flow Growth
-53.8%
Year-over-Year
Financing Cash Flow Growth
+233.3%
Year-over-Year

GODAVARI Income Statement — Revenue, EBITDA & Net Profit

Godavari Drugs revenue ₹99 Cr, EBITDA ₹12 Cr, net profit ₹4 Cr, EPS ₹4.90 (None) — net profit margin 3.5%. Review GODAVARI P/E comparison to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 99 114 157 160 161 123 96 84 65 76 71 55
Expenses 88 102 143 150 150 113 90 78 60 70 67 49
EBITDA 12 13 14 11 12 10 6 6 5 6 5 6
Operating Profit Margin % 11.00% 10.00% 8.00% 6.00% 7.00% 8.00% 6.00% 7.00% 6.00% 7.00% 6.00% 11.00%
Depreciation 3 2 2 2 2 1 1 1 1 1 1 1
Interest 4 5 5 4 3 3 3 3 2 3 2 1
Profit Before Tax 5 6 7 5 7 6 2 2 1 3 2 5
Tax 1 1 1 1 2 2 0 1 1 1 1 1
Net Profit 4 4 6 4 5 4 2 1 1 2 1 4
Earnings Per Share (₹) 4.90 5.82 7.37 5.03 6.97 5.48 2.66 1.60 1.10 2.40 1.79 4.84

GODAVARI Balance Sheet — Assets, Liabilities & Shareholders' Equity

GODAVARI total assets ₹143 Cr, total equity ₹43 Cr, total liabilities ₹ Cr (2025) — ROE 9.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 143 135 121 101 91 84 74 63 56 51 35
Current Assets 79 89 87 74 68 61 57 47 43 40 27
Fixed Assets 33 27 25 26 22 14 15 15 13 9 7
Capital Work in Progress 30 18 9 1 1 9 2 1 0 1 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 81 90 87 75 68 61 57 48 43 41 27
LIABILITIES
Total Liabilities
Current Liabilities 27 14 14 14 16 12 9 9 6 5 5
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 43 39 33 30 24 20 18 17 16 14 13
Share Capital 8 8 8 8 8 8 8 8 8 8 8
Reserves & Surplus 36 31 26 22 17 13 11 10 9 7 6

GODAVARI Cash Flow Statement — Operating, Investing & Financing

Godavari Drugs operating cash flow ₹11 Cr, investing ₹-20 Cr, financing ₹8 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 11 18 13 11 1 6 4 4 5 -5 -6
Investing Activities -20 -13 -9 -5 -1 -7 -2 -3 -3 -2 0
Financing Activities 8 -6 -4 -6 0 0 -2 0 -2 7 6
Net Cash Flow 0 -1 1 1 0 0 0 1 0 0 0